Education
About Us
Working with TipRanks
Follow Us
Novo Nordisk (NVO)
NYSE:NVO
Total Valuation
Novo Nordisk has a market cap or net worth of $307.75B. The enterprise value is ―.
Market Cap$307.75B
Enterprise Value―
Share Statistics
Novo Nordisk has 3,390,128,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,390,128,000
Owned by Insiders―
Owned by Institutions4.70%
Financial Efficiency
Novo Nordisk’s return on equity (ROE) is 0.70 and return on invested capital (ROIC) is 38.99%.
Return on Equity (ROE)0.70
Return on Assets (ROA)0.22
Return on Invested Capital (ROIC)38.99%
Return on Capital Employed (ROCE)0.52
Revenue Per Employee3.75M
Profits Per Employee1.30M
Employee Count77,406
Asset Turnover0.62
Inventory Turnover1.09
Valuation Ratios
The current PE Ratio of Novo Nordisk is 27.32. Novo Nordisk’s PEG ratio is 3.15.
PE Ratio27.32
PS Ratio0.00
PB Ratio14.82
Price to Fair Value19.23
Price to FCF29.96
Price to Operating Cash Flow17.58
PEG Ratio3.15
Income Statement
In the last 12 months, Novo Nordisk had revenue of 290.40B and earned 100.99B in profits. Earnings per share was 22.68.
Revenue290.40B
Gross Profit245.88B
Operating Income128.34B
Pretax Income127.19B
Net Income100.99B
EBITDA137.38B
Earnings Per Share (EPS)22.68
Cash Flow
In the last 12 months, operating cash flow was 120.97B and capital expenditures -50.92B, giving a free cash flow of 70.04B billion.
Operating Cash Flow120.97B
Free Cash Flow70.04B
Free Cash Flow per Share20.66
Dividends & Yields
Novo Nordisk pays an annual dividend of $0.787, resulting in a dividend yield of 1.73%
Dividend Per Share$0.787
Dividend Yield1.73%
Payout Ratio33.95%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.90
52-Week Price Change-49.01%
50-Day Moving Average67.37
200-Day Moving Average96.15
Relative Strength Index (RSI)53.92
Average Volume (3m)11.70M
Important Dates
Novo Nordisk upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.
Last Earnings DateMay 7, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend DateMar 31, 2025
Financial Position
Novo Nordisk as a current ratio of 0.74, with Debt / Equity ratio of 71.64%
Current Ratio0.74
Quick Ratio0.55
Debt to Market Cap0.03
Net Debt to EBITDA0.63
Interest Coverage Ratio78.26
Taxes
In the past 12 months, Novo Nordisk has paid 26.20B in taxes.
Income Tax26.20B
Effective Tax Rate0.21
Enterprise Valuation
Novo Nordisk EV to EBITDA ratio is 20.72, with an EV/FCF ratio of 40.86.
EV to Sales9.80
EV to EBITDA20.72
EV to Free Cash Flow40.86
EV to Operating Cash Flow23.53
Balance Sheet
Novo Nordisk has $26.31B in cash and marketable securities with kr102.79B in debt, giving a net cash position of $76.48B billion.
Cash & Marketable Securities$26.31B
Total Debtkr102.79B
Net Cash$76.48B
Net Cash Per Share$22.56
Tangible Book Value Per Share$7.27
Margins
Gross margin is 84.67%, with operating margin of 44.19%, and net profit margin of 34.78%.
Gross Margin84.67%
Operating Margin44.19%
Pretax Margin43.80%
Net Profit Margin34.78%
EBITDA Margin47.31%
EBIT Margin44.36%
Analyst Forecast
The average price target for Novo Nordisk is $92.30, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$92.30
Price Target Upside35.40% Upside
Analyst ConsensusHold
Analyst Count9
Revenue Growth Forecast22.74%
EPS Growth Forecast16.36%